Fanconi anemia complementation group D2 (FANCD2) is involved in the regulation of tumorigenesis, apoptosis, and other life processes in cancers [6], such as glioblastoma [7], esophageal squamous cell carcinoma (ESCC) [8], and lung adenocarcinoma [9]. This evidence concerns the gene FANCD2 and cancer.